APOA1 and hepatocellular carcinoma: Other studies reported that ApoA-I serum levels were significantly decreased in HCC patients with recurrent disease, as compared to patients in remission, and patients with acute lymphoblastic leukemia who achieved remission after receiving chemotherapy displayed significant increases in ApoA-I levels [100,137].